The 4th Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical development, translation, manufacturing, supply and storage of allogeneic cell therapies to improve the accessibility and efficacy of patient care worldwide.
400+ experts from pharma, biotech and leading academia are expected to attend in Boston, USA 9-12 May 2022 to uncover best-in-class approaches to overcome.
Alan Trounson – Cartherics’ CEO will be there.
Read more about it here:
